Ernesto Canalis, MDProfessor of Orthopedic Surgery and Medicine, UConn HealthDirector of Center for Skeletal Research, UConn Health UConn Musculoskeletal Institute
|
- Overview
- Education & Training
- Committees & Organizations
- Research
- Lab Rotations
- Publications
- Presentations
Dr. Canalis is a Professor of Orthopedics and Medicine in the UConn Musculoskeletal Institute at UConn Health and Director of the Center for Skeletal Research. He is an internationally renowned expert in bone metabolism. Dr. Canalis’ clinical interests include osteoporosis and metabolic bone disorders. He sees patients at the Center for Osteoporosis in the UConn Musculoskeletal Institute.
Degree | Institution | Major |
---|---|---|
MD | Universidad Peruana Cayetano Heredia | Medicine |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Internship | UConn School of Medicine | Internal Medicine |
Residency | Henry Ford Hospital | Internal Medicine |
Residency | UConn School of Medicine | Internal Medicine |
Fellowship | Tufts-New England Medical Center | Endocrinology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Lawrence G. Raisz Award for Outstanding Achievements in Preclinical Translational Research | American Society for Bone and Mineral Research |
Distinguished Physician Award, Medical Staff | Saint Francis Hospital and Medical Center |
Louis V. Avioli Founders Award for Fundamental Contributions to Bone and Mineral Basic Research | American Society for Bone and Mineral Research |
Marshall Urist Award for Excellence in Tissue Regeneration Research | Orthopaedic Research Society |
Gerald D. Aurbach Award for Outstanding Research in Endocrinology | Endocrine Society |
MERIT Award | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
Ann Doner Vaughan Kappa Delta Award for Excellence in Orthopaedic Research | American Academy of Orthopaedic Surgeons |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
UConn Health Research Council | Research Committee | Member | UConn Health | University | 2019 | |
J. Clinical Densitometry | Editorial Board | Member | External | National | 2019 | |
Recruitment of Basic Scientist and of Director of MicroCT Core | Other | Chair | UConn Health | University | 2018 | |
National Institutes of Health | Study Section | Chair | External | International | 2016 | 2018 |
Shriners Hospitals for Children Research Program | Other | Grant Reviewer | External | National | 2015 | |
NIH Center for Scientific Review, Skeletal Biology Development and Disease Study Section | Study Section | Appointed Member | External | International | 2014 | 2018 |
European Journal of Endocrinology | Editorial Board | Associate Editor for North America | External | International | 2012 | 2020 |
Calcified International | Editorial Board | External | International | 1989 |
The Canalis laboratory is known for the discovery of skeletal growth factors and has pursued important investigations on the role of growth factors and their antagonists in skeletal function. Dr. Canalis’ group has made seminal contributions to our understanding of the mechanisms of glucocorticoid action in bone in an effort to explain the pathogenesis of glucocorticoid induced osteoporosis and correct the disease. The laboratory’s recent work has centered on factors determining osteoblast and osteoclast cell fate and function. These investigations include studies on the role of Notch signaling and Nuclear factor of activated T cells (NFAT) in osteoblast and osteoclast cell differentiation. Cellular and genetically engineered mouse models are used for the research conducted by the group. The laboratory is particularly interested in translational research and has created genetically engineered mouse models of Hajdu Cheney Syndrome and Lateral Meningocele Syndrome, devastating diseases characterized by bone loss and fractures. The studies have allowed the team to determine mechanisms of the bone loss and are exploring ways to prevent the skeletal disease.The laboratory has been funded continuously by the National Institutes of Health (NIH) since the 1981, and in 1990 received a MERIT Award from the National Institute of Musculoskeletal and Skin Disorders (NIAMS). Currently, the laboratory is funded by NIAMS and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Accepting Lab Rotation Students: Fall Block 2024, Spring 1 and 2 Block 2025
Projects available include
--Role of Hes1 in osteoclast differentiation and function
--Role of Nfat in osteoblast differentiation and function; in vivo and in vitro studies
--Characterization of genetically engineered mice carrying Notch2 or Notch3 mutations
--Role of Notch in osteocyte function --Role of vascular Notch in skeletal homeostasis --Targeting Notch mutations to reverse skeletal phenotypes
Journal Articles
-
NOTCH2 Promotes Osteoclast Maturation and Metabolism and Modulates the Transcriptome Profile During Osteoclastogenesis.
The Journal of biological chemistry 2023 Dec;105613
-
Antisense oligonucleotides targeting a NOTCH3 mutation in male mice ameliorate the cortical osteopenia of lateral meningocele syndrome.
Bone 2023 Dec;177116898
-
NOTCH Sensitizes the Chondrocyte to the Inflammatory Response of Tumor Necrosis Factor α.
The Journal of biological chemistry 2023 Oct;105372
-
Induced pluripotent stem cell technology in bone biology.
Bone 2023 Jul;172116760
-
Induction of a NOTCH3 Lehman syndrome mutation in osteocytes causes osteopenia in male C57BL/6J mice.
Bone 2022 Sep;162116476
-
Role of nuclear factor of activated T cells in chondrogenesis osteogenesis and osteochondroma formation.
Journal of endocrinological investigation 2022 Mar;
-
Use of antisense oligonucleotides to target Notch3 in skeletal cells.
PloS one 2022 Jan;17(5):e0268225
-
Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
The Journal of biological chemistry 2021 Nov;297(6):101376
-
Remembering Dr John D Termine: September 25, 1938 - June 3, 2021.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021 Jul;
-
Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
The Journal of biological chemistry 2021 Mar;100583
-
Notch and the regulation of osteoclast differentiation and function.
Bone 2020 Jun;138115474
-
Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis.
European journal of endocrinology 2020 May;
-
Nuclear factor of activated T cells 1 and 2 are required for vertebral homeostasis.
Journal of cellular physiology 2020 Apr;
-
Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu Cheney syndrome.
The Journal of biological chemistry 2020 Jan;
-
The Skeleton of Lateral Meningocele Syndrome.
Frontiers in genetics 2020 Jan;11620334
-
The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
The Journal of Biological Chemistry 2019 Aug;294(39):14203-14214
-
Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.
Journal of Immunology (Baltimore, Md. : 1950) 2019 Jul;203(1):105-116
-
An Antibody to Notch3 Reverses the Skeletal Phenotype of Lateral Meningocele Syndrome in Male Mice.
Journal of Cellular Physiology 2019 Jun;235(1):210-220
-
MANAGEMENT OF ENDOCRINE DISEASE: Bone Disorders Associated with Acromegaly: Mechanisms and Treatment.
European Journal of Endocrinology 2019 May;181R45-R56
-
Excessive Mechanical Loading Promotes Osteoarthritis through the Gremlin-1-NF-κB Pathway.
Nature Communications 2019 Mar;10(1):1442
-
The Lateral Meningocele Syndrome Mutation Causes Marked Osteopenia in Mice
The Journal of Biological Chemistry 2018 Jul;293(36):14165-14177
-
Nuclear factor of Activated T Cells 2 is Required for Osteoclast Differentiation and Function In Vitro but not In Vivo
Journal of Cellular Biochemistry 2018 Jul;119(11):9334-9345
-
Mice Harboring a Hajdu Cheney Syndrome Mutation are Sensitized to Osteoarthritis
Bone 2018 Jun;114198-205
-
Glucocorticoids Inhibit Notch Target Gene Expression in Osteoblasts
Journal of Cellular Biochemistry 2018 Mar;119(7):6016-6023
-
Induction of the Hajdu Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis
The American Journal of Pathology 2018 Mar;188(6):1430-1446
-
Clinical and Experimental Aspects of Notch Receptor Signaling: Hajdu-Cheney Syndrome and Related Disorders
Metabolism: Clinical and Experimental 2018 Mar;8048-56
-
MANAGEMENT OF ENDOCRINE DISEASE: Novel Anabolic Treatments for Osteoporosis
European journal of endocrinology 2017 Nov;178(2):R33-R44
-
The Hajdu Cheney Mutation is a Determinant of B Cell Allocation of the Splenic Marginal Zone
The American Journal of Pathology 2017 Oct;188(1):149-159
-
Parathyroid Hormone Inhibits Notch Signaling in Osteoblasts and Osteocytes
Bone 2017 Jul;103159-167
-
Sustained Notch2 Signaling in Osteoblasts, but no in Osteoclasts, is Linked to Osteopenia in a Mouse Model of Hajdu-Cheney Syndrome
The Journal of Biological Chemistry 2017 Jun;292(29):12232-12244
-
Hairy and Enhancer of Split-related with YRPW Motif-Like (HeyL) is Dispensable for Bone Remodeling in Mice.
Journal of cellular biochemistry 2016 Dec;1181819-1826
-
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Bone 2016 Aug;92150-156
-
Effects of sex and notch signaling on the osteocyte cell pool.
Journal of cellular physiology 2016 May;232363-370
-
NOTCH SIGNALING AND THE SKELETON.
Endocrine reviews 2016 Apr;37223-53
-
Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis and Bone Resorption.
The Journal of Biological Chemistry 2015 Dec;2911538-51
-
CANONICAL NOTCH ACTIVATION IN OSTEOCYTES CAUSES OSTEOPETROSIS.
American journal of physiology. Endocrinology and metabolism 2015 Nov;310E171-82
-
The Dmp1-SOST Transgene Interacts With and Downregulates the Dmp1-Cre Transgene and the Rosa(Notch) Allele.
Journal of cellular biochemistry 2015 Oct;1171222-32
-
Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss.
Endocrinology 2015 Jul;156(11):4129-40
-
Activation of Nfatc2 in osteoblasts causes osteopenia.
Journal of cellular physiology 2015 Jan;230(7):1689-95
-
Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
PloS one 2015 Jan;10(3):e0120164
-
Connective tissue growth factor is a target of notch signaling in cells of the osteoblastic lineage.
Bone 2014 Jul;64273-80
-
Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.
Bone 2014 May;6222-8
-
Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2014 Apr;29(5):1217-31
-
Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor.
American journal of physiology. Lung cellular and molecular physiology 2014 Apr;306(8):L786-96
-
Nemo-like kinase regulates postnatal skeletal homeostasis.
Journal of cellular physiology 2014 Mar;229(11):1736-43
-
Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells.
PloS one 2014 Jan;9(1):e86757
-
Osteoblast lineage-specific effects of notch activation in the skeleton.
Endocrinology 2013 Feb;154(2):623-34
-
Nuclear factor of activated T-cells (NFAT)C2 inhibits Notch receptor signaling in osteoblasts.
The Journal of biological chemistry 2013 Jan;288(1):624-32
-
Conditional inactivation of noggin in the postnatal skeleton causes osteopenia.
Endocrinology 2012 Apr;153(4):1616-26
-
Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts.
The Journal of biological chemistry 2011 Feb;286(6):4576-88
-
HES1 (hairy and enhancer of split 1) is a determinant of bone mass.
The Journal of biological chemistry 2011 Jan;286(4):2648-57
-
BMD regulation on mouse distal chromosome 1, candidate genes, and response to ovariectomy or dietary fat.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011 Jan;26(1):88-99
-
Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
Bone 2010 Sep;47(3):573-82
-
Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.
Endocrinology 2010 Aug;151(8):3490-501
-
Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage.
Journal of cellular biochemistry 2010 May;110(2):477-83
-
A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis.
The Journal of endocrinology 2010 Mar;204(3):241-53
-
Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.
Endocrinology 2010 Jan;151(1):221-33
-
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009 Aug;24(8):1481-92
-
Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.
The Journal of endocrinology 2009 May;201(2):263-74
-
PPARG by dietary fat interaction influences bone mass in mice and humans.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008 Sep;23(9):1398-408
-
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
Endocrinology 2008 Sep;149(9):4374-81
-
Connective tissue growth factor enhances osteoblastogenesis in vitro.
The Journal of biological chemistry 2008 Aug;283(33):22690-9
-
Notch inhibits osteoblast differentiation and causes osteopenia.
Endocrinology 2008 Aug;149(8):3890-9
-
Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2.
Journal of cellular biochemistry 2008 Jul;104(4):1421-6
-
A soluble activin type IIA receptor induces bone formation and improves skeletal integrity.
Proceedings of the National Academy of Sciences of the United States of America 2008 May;105(19):7082-7
-
Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.
Endocrinology 2008 May;149(5):2051-61
-
The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome.
Development (Cambridge, England) 2008 May;135(9):1713-23
-
Transgenic overexpression of gremlin results in developmental defects in enamel and dentin in mice.
Connective tissue research 2008 Jan;49(6):391-400
-
Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.
The Journal of biological chemistry 2007 Oct;282(43):31549-57
-
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007 Aug;22(8):1197-207
-
Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007 Aug;22(8):1187-96
-
Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
The Journal of biological chemistry 2007 Jul;282(27):19762-72
-
CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.
Bone 2007 Mar;40(3):619-26
-
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Bone 2006 Dec;39(6):1252-60
-
Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 Aug;21(8):1317-26
-
Expression and regulation of CCN genes in murine osteoblasts.
Bone 2006 May;38(5):671-7
-
The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
The Journal of endocrinology 2006 May;189(2):289-99
-
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling.
The Journal of biological chemistry 2006 Mar;281(10):6203-10
-
C/EBP homologous protein is necessary for normal osteoblastic function.
Journal of cellular biochemistry 2006 Feb;97(3):633-40
-
Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro.
Endocrinology 2005 Sep;146(9):3875-82
-
Overexpression of IGF-binding protein 5 alters mineral and matrix properties in mouse femora: an infrared imaging study.
Calcified tissue international 2005 Mar;76(3):187-93
-
Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.
Journal of cellular physiology 2005 Feb;202(2):391-9
-
AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts.
The Journal of biological chemistry 2004 Dec;279(7):5397-404
-
Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro.
Bone 2004 Dec;35(6):1256-62
-
Effects of activated T cells on osteoclastogenesis depend on how they are activated.
Bone 2004 Sep;35(3):614-20
-
Transgenic mice expressing selected insulin-like growth factor-binding protein-5 fragments do not exhibit enhanced bone formation.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2004 Aug;14(4):319-27
-
CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation.
Endocrinology 2004 Apr;145(4):1952-60
-
Notch 1 impairs osteoblastic cell differentiation.
Endocrinology 2003 Dec;144(12):5631-9
-
Transcriptional regulation of collagenase-3 by interleukin-1 alpha in osteoblasts.
Journal of cellular biochemistry 2003 Dec;90(5):1007-14
-
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Jun;18(6):1005-11
-
Skeletal overexpression of noggin results in osteopenia and reduced bone formation.
Endocrinology 2003 May;144(5):1972-8
-
Noggin arrests stromal cell differentiation in vitro.
Bone 2003 Feb;32(2):111-9
-
Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.
Endocrinology 2002 Oct;143(10):3955-62
-
Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.
Bone 2002 May;30(5):685-91
-
Cortisol regulates the expression of Notch in osteoblasts.
Journal of cellular biochemistry 2002 Jan;85(2):252-8
-
Glucocorticoid suppression of IGF I transcription in osteoblasts.
Molecular endocrinology (Baltimore, Md.) 2001 Oct;15(10):1781-9
-
Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture.
Bone 2001 May;28(5):484-90
-
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Endocrinology 2001 Apr;142(4):1561-6
-
Alendronate stimulates collagenase 3 expression in osteoblasts by posttranscriptional mechanisms.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000 Dec;15(12):2345-51
-
Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
Endocrinology 2000 Dec;141(12):4558-63
-
Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex.
Journal of cellular physiology 2000 Sep;184(3):326-33
-
Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts.
American journal of physiology. Endocrinology and metabolism 2000 Sep;279(3):E570-6
-
Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site.
Endocrinology 2000 Jun;141(6):2185-91
-
Osteopenia and decreased bone formation in osteonectin-deficient mice
The Journal of clinical investigation 2000 May;105(9):1325
-
Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts.
American journal of physiology. Endocrinology and metabolism 2000 Mar;278(3):E509-15
-
Transforming growth factor-beta increases interleukin-6 transcripts in osteoblasts.
Bone 2000 Mar;26(3):249-53
-
Bone morphogenetic protein-4 regulates its own expression in cultured osteoblasts.
Journal of cellular physiology 2000 Feb;182(2):239-46
-
Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts.
The American journal of physiology 1999 Sep;277(3 Pt 1):E496-504
-
Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts.
Endocrinology 1999 May;140(5):1998-2003
-
Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2.
The Journal of biological chemistry 1999 Mar;274(10):6783-9
-
Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts.
Endocrinology 1999 Mar;140(3):1069-74
-
Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts.
The American journal of physiology 1999 Mar;276(3 Pt 1):E465-71
-
Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts.
Endocrinology 1999 Feb;140(2):562-7
-
Cortisol enhances the expression of mac25/insulin-like growth factor-binding protein-related protein-1 in cultured osteoblasts.
Endocrinology 1999 Jan;140(1):228-32
-
Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.
The Journal of clinical investigation 1998 Dec;102(12):2106-14
-
Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone.
Journal of cellular biochemistry 1998 Dec;71(3):449-58
-
Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts.
The American journal of physiology 1998 Aug;275(2 Pt 1):E222-8
-
Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts.
The Journal of biological chemistry 1998 Jun;273(26):16595-600
-
Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone.
Endocrinology 1998 May;139(5):2287-92
-
Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts.
The American journal of physiology 1998 Mar;274(3 Pt 1):C734-40
-
Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-I in osteoblasts.
Endocrinology 1997 Dec;138(12):5248-55
-
Insulin-like growth factor I inhibits the transcription of collagenase 3 in osteoblast cultures.
Journal of cellular biochemistry 1997 Nov;67(2):176-83
-
Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.
The Journal of clinical investigation 1997 Oct;100(7):1797-803
-
Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
Endocrinology 1997 Aug;138(8):3380-6
-
Retinoic acid regulates the expression of insulin-like growth factors I and II in osteoblasts.
Journal of cellular physiology 1997 Aug;172(2):253-64
-
Growth factor regulation of insulin-like growth factor binding protein-6 expression in osteoblasts.
Journal of cellular biochemistry 1997 Jul;66(1):77-86
-
Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures.
The Journal of biological chemistry 1997 May;272(18):12144-50
-
Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures.
Endocrinology 1997 Mar;138(3):1035-40
-
Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures.
Journal of cellular physiology 1997 Feb;170(2):145-52
-
Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors.
Endocrinology 1996 Nov;137(11):4665-70
-
Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.
The Journal of clinical endocrinology and metabolism 1996 Oct;81(10):3441-7
-
Expression and growth factor regulation of platelet-derived growth factor B transcripts in primary osteoblast cell cultures.
Endocrinology 1996 Oct;137(10):4115-9
-
Retinoic acid stimulates the transcription of insulin-like growth factor binding protein-6 in skeletal cells.
Journal of cellular physiology 1996 Oct;169(1):15-22
-
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro.
Bone 1996 Jun;18(6):517-23
-
Transcriptional regulation of insulin-like growth factor-binding protein-5 by prostaglandin E2 in osteoblast cells.
Endocrinology 1996 Jun;137(6):2375-82
-
Cortisol enhances the transcription of insulin-like growth factor-binding protein-6 in cultured osteoblasts.
Endocrinology 1996 May;137(5):1687-92
-
Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms.
The Journal of biological chemistry 1996 Apr;271(15):9033-8
-
Transcriptional and posttranscriptional regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures.
Endocrinology 1996 Feb;137(2):431-7
-
Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage.
Endocrinology 1995 Dec;136(12):5469-75
-
Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms.
The Journal of biological chemistry 1995 Nov;270(44):26607-12
-
Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells.
Endocrinology 1995 Nov;136(11):4776-81
-
Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures.
Endocrinology 1995 Oct;136(10):4254-60
-
Bone morphogenetic protein-2 inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures.
Endocrinology 1995 Jun;136(6):2397-403
-
Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures.
The Journal of biological chemistry 1995 May;270(18):10771-6
-
Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells.
Endocrinology 1995 May;136(5):2156-62
-
Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells.
Endocrinology 1995 May;136(5):2000-6
-
Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures.
Endocrinology 1995 Apr;136(4):1348-54
-
Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.
Journal of cellular biochemistry 1995 Mar;57(3):488-94
-
Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells.
Endocrinology 1995 Jan;136(1):33-8
-
Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Dec;9(12):1999-2005
-
Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.
Journal of cellular physiology 1994 Aug;160(2):255-64
-
Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
Journal of cellular physiology 1994 Jul;160(1):163-75
-
Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors.
Endocrinology 1994 Jul;135(1):284-9
-
Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures.
Endocrinology 1994 Jun;134(6):2541-6
-
Regulation of interstitial collagenase expression and collagen degradation by retinoic acid in bone cells.
Endocrinology 1994 Jun;134(6):2438-44
-
Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts.
Endocrinology 1994 Mar;134(3):1423-8
-
Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I.
Endocrinology 1993 Oct;133(4):1504-10
-
Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures.
Endocrinology 1993 Jul;133(1):33-8
-
Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992 Sep;7(9):1085-92
-
Determination and expression of platelet-derived growth factor-AA in bone cell cultures.
Endocrinology 1992 Apr;130(4):1916-22
-
Isoform-specific regulation of platelet-derived growth factor activity and binding in osteoblast-enriched cultures from fetal rat bone.
The Journal of clinical investigation 1992 Apr;89(4):1076-84
-
Constitutive synthesis of insulin-like growth factor-II by primary osteoblast-enriched cultures from fetal rat calvariae.
Endocrinology 1992 Mar;130(3):1303-8
-
Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone.
Molecular and cellular biology 1991 Sep;11(9):4490-6
-
Effects of desamino-(1-3)-insulin-like growth factor I on bone cell function in rat calvarial cultures.
Endocrinology 1991 Jul;129(1):534-41
-
Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone.
Endocrinology 1991 Jun;128(6):2895-900
-
Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone.
Journal of cellular physiology 1991 Jun;147(3):420-6
-
Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.
Molecular and cellular biology 1991 Jan;11(1):250-8
-
Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures.
The Journal of biological chemistry 1990 Sep;265(26):15353-6
-
Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells.
Molecular and cellular biology 1990 Sep;10(9):4473-9
-
Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis.
Endocrinology 1990 Apr;126(4):1806-12
-
Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.
Endocrinology 1990 Mar;126(3):1569-75
-
Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.
Endocrinology 1990 Jan;126(1):39-44
-
Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae.
Endocrinology 1990 Jan;126(1):421-6
-
Beta 2-microglobulin enhances insulin-like growth factor I receptor levels and synthesis in bone cell cultures.
The Journal of biological chemistry 1989 Nov;264(31):18268-71
-
Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells.
Endocrinology 1989 Oct;125(4):2118-26
-
Effects of platelet-derived growth factor on bone formation in vitro.
Journal of cellular physiology 1989 Sep;140(3):530-7
-
Parathyroid hormone-related protein modulates the effect of transforming growth factor-beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells.
Endocrinology 1989 Jul;125(1):199-208
-
Platelet-derived growth factor enhances deoxyribonucleic acid and collagen synthesis in osteoblast-enriched cultures from fetal rat parietal bone.
Endocrinology 1989 Jul;125(1):13-9
-
Analysis of hydroxyproline by high performance liquid chromatography and its application to collagen turnover studies in bone cultures.
Calcified tissue international 1989 Jun;44(6):421-4
-
Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone.
Endocrinology 1989 Mar;124(3):1247-53
-
Scanning electron microscopy and gel electrophoresis of vascularized periosteal autografts.
Plastic and reconstructive surgery 1989 Mar;83(3):500-10
-
Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.
The Journal of clinical investigation 1989 Jan;83(1):60-5
-
Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures.
Endocrinology 1989 Jan;124(1):301-9
-
Isolation of growth factors from adult bovine bone.
Calcified tissue international 1988 Dec;43(6):346-51
-
Skeletal tissue and transforming growth factor beta.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1988 Dec;2(15):3066-73
-
Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures.
Endocrinology 1988 Sep;123(3):1442-8
-
Further biochemical and molecular characterization of primary rat parietal bone cell cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1988 Aug;3(4):401-8
-
Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone.
Proceedings of the National Academy of Sciences of the United States of America 1988 Aug;85(16):5889-93
-
Effects of basic fibroblast growth factor on bone formation in vitro.
The Journal of clinical investigation 1988 May;81(5):1572-7
-
Growth factors and the regulation of bone remodeling.
The Journal of clinical investigation 1988 Feb;81(2):277-81
-
Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae.
Bone 1988 Jan;9(4):243-6
-
Insulin-like growth factor I has independent effects on bone matrix formation and cell replication.
Endocrinology 1988 Jan;122(1):254-60
-
Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae.
Endocrinology 1988 Jan;122(1):22-7
-
Effects of tumor necrosis factor on bone formation in vitro.
Endocrinology 1987 Nov;121(5):1596-604
-
Mitogenesis in fetal rat bone cells simultaneously exposed to type beta transforming growth factor and other growth regulators.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1987 Oct;1(4):312-7
-
A bone-derived growth factor isolated from rat calvariae is beta 2 microglobulin.
Endocrinology 1987 Sep;121(3):1198-200
-
Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.
The Journal of biological chemistry 1987 Feb;262(6):2869-74
-
Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1987 Feb;2(1):29-36
-
Effects of endothelial cell growth factor on bone remodelling in vitro.
The Journal of clinical investigation 1987 Jan;79(1):52-8
-
Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae.
Endocrinology 1986 Nov;119(5):2306-12
-
Isolation of a nontransforming bone-derived growth factor from medium conditioned by fetal rat calvariae.
Endocrinology 1986 May;118(5):2002-8
-
Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae.
Endocrinology 1986 Jan;118(1):74-81
-
Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae.
Proceedings of the National Academy of Sciences of the United States of America 1985 Nov;82(21):7335-9
-
Effect of partially purified bone morphogenetic protein on DNA synthesis and cell replication in calvarial and fibroblast cultures.
Clinical orthopaedics and related research 1985 Sep;(198):289-96
-
Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvariae.
The Journal of biological chemistry 1985 Jul;260(15):8706-10
-
Effect of sodium vanadate on deoxyribonucleic acid and protein syntheses in cultured rat calvariae.
Endocrinology 1985 Mar;116(3):855-62
-
1,25-Dihydroxyvitamin D3 effects on collagen and DNA synthesis in periosteum and periosteum-free calvaria.
Bone 1985 Jan;6(6):457-60
-
Characterization of the effect of insulin on collagen synthesis in fetal rat bone.
Endocrinology 1985 Jan;116(1):296-302
-
Local regulators of skeletal growth: a perspective.
Endocrine reviews 1985 Jan;6(4):544-51
-
Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae.
Calcified tissue international 1984 Mar;36(2):158-66
-
Effect of cartilage-derived factor on DNA and protein synthesis in cultured rat calvariae.
Calcified tissue international 1984 Jan;36(1):102-7
-
Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.
Endocrinology 1983 Mar;112(3):931-9
-
Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae.
Metabolism: clinical and experimental 1983 Jan;32(1):14-20
-
A more specific, liquid-chromatographic method for free cortisol in urine.
Clinical chemistry 1982 Dec;28(12):2418-20
-
Effect of bone-derived growth factor on DNA, RNA, and proteoglycan synthesis in cultures of rabbit costal chondrocytes.
Metabolism: clinical and experimental 1982 Aug;31(8):812-5
-
Selective stimulation of sulfated glycosaminoglycan synthesis by multiplication-stimulating activity, cartilage-derived factor and bone-derived growth factor. Comparison of their actions on cultured chondrocytes with those of fibroblast growth factor and Rhodamine fibrosarcoma-derived growth factor.
Biochimica et biophysica acta 1982 May;716(2):232-9
-
Analysis for cortisol in serum by liquid chromatography.
Clinical chemistry 1982 Mar;28(3):538-43
-
Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria.
Metabolism: clinical and experimental 1981 Oct;30(10):970-5
-
Determination of serum 17 alpha-hydroxyprogesterone by liquid chromatography.
Clinical chemistry 1981 Jul;27(7):1241-3
-
Stimulation of DNA and collagen synthesis by autologous growth factor in cultured fetal rat calvaria.
Science (New York, N.Y.) 1980 Nov;210(4473):1021-3
-
Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria.
The Journal of clinical investigation 1980 Oct;66(4):709-19
-
The generation of sulfation factor activity by proteolytic modification of growth hormone.
The Journal of biological chemistry 1980 Jul;255(13):6064-70
-
Direct stimulation of bone resorption by epidermal growth factor.
Endocrinology 1980 Jul;107(1):270-3
-
Hyperparathyroidism in the elderly.
American journal of surgery 1980 Apr;139(4):581-5
-
Effect of fibroblast growth factor on cultured fetal rat calvaria.
Metabolism: clinical and experimental 1980 Feb;29(2):108-14
-
Serum cortisol and 11 deoxycortisol by liquid chromatography: clinical studies and comparison with radioimmunoassay.
Clinical chemistry 1979 Oct;25(10):1700-3
-
Effect of epidermal growth factor on bone formation in vitro.
Endocrinology 1979 Apr;104(4):862-9
-
Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro.
Endocrinology 1979 Mar;104(3):715-21
-
Determination of serum cortisol and 11-deoxycortisol by liquid chromatography.
Clinical chemistry 1979 Jan;25(1):122-6
-
Abnormal gonadotropin secretory responses to LRH in transsexual women after diethylstilbestrol priming.
The Journal of clinical endocrinology and metabolism 1978 Jul;47(1):176-83
-
Effect of sex steroids on bone collagen synthesis in vitro.
Calcified tissue research 1978 May;25(2):105-10
-
Hormonal control of bone collagen synthesis in vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites.
Endocrinology 1978 Mar;102(3):731-5
-
Effect of somatomedin and growth hormone on bone collagen synthesis in vitro.
Metabolism: clinical and experimental 1977 Oct;26(10):1079-87
-
Hormonal control of bone collagen synthesis in vitro. Effects of insulin and glucagon.
Endocrinology 1977 Mar;100(3):668-74
-
Direct stimulation of bone resorption by thyroid hormones.
The Journal of clinical investigation 1976 Sep;58(3):529-34
-
Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin.
Endocrinology 1976 Apr;98(4):943-9
-
Factors influencing bone formation in organ culture.
Israel journal of medical sciences 1976 Feb;12(2):108-14
-
Role of Nuclear Factor of Activated T Cells in Chondrogenesis Osteogenesis and Osteochondroma Formation
Journal of Endocrinological Investigation
-
Use of Antisense Oligonucleotides to Target Notch3 in Skeletal Cells
PLoS One 17(5):e0268225
Book Chapters
-
Glucocorticoid-induced Osteoporosis
Oxford Textbook of Endocrinology and Diabetes 2022 Jun;
-
Role of Notch Signaling in Bone Remodeling and Skeletal Diseases
Encylopedia of Bone Biology 2020 Jun;
-
Notch and its Ligands
Principles of Bone Biology 4e 2019 Aug;21083-1112
-
Glucocorticoid-induced Osteoporosis
Oxford Textbook of Endocrinology and Diabetes 3e 2018 (In Press)
-
Glucocorticoid-induced Osteoporosis
Oxford Textbook of Endocrinology and Diabetes 2018 - (In Press)
-
Notch Signaling in Skeletal Diseases
Encylopedia of Bone Biology 130-140
-
Skeletal Growth Factors
Marcus and Feldman’s Osteoporosis, 5th Edition 235-256
Conference Papers
-
Osteonectin-null mutation compromises osteoblast formation, maturation, and survival.
Endocrinology 2003 Jun;144(6):2588-96
Erratums
-
Correction to: Notch in skeletal physiology and disease.
Osteoporosis International 2018 Oct;30251
Reviews
-
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases.
Endocrine 2024 Apr;
-
Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis.
Nature reviews. Endocrinology 2022 Mar;
-
Notch in Skeletal Physiology and Disease
Osteoporosis International 2018 Sep;29(12):2611-2621
-
Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
Current osteoporosis reports 2016 May;14126-31
-
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
European journal of endocrinology / European Federation of Endocrine Societies 2015 May;173(3):R131-51
-
Hajdu-Cheney syndrome: a review.
Orphanet journal of rare diseases 2014 Dec;9(1):200
-
Update in new anabolic therapies for osteoporosis.
The Journal of clinical endocrinology and metabolism 2010 Apr;95(4):1496-504
-
Growth hormone, insulin-like growth factors, and the skeleton.
Endocrine reviews 2008 Aug;29(5):535-59
-
Mechanisms of anabolic therapies for osteoporosis.
The New England journal of medicine 2007 Aug;357(9):905-16
-
Perspectives on glucocorticoid-induced osteoporosis.
Bone 2004 Apr;34(4):593-8
-
Bone morphogenetic proteins, their antagonists, and the skeleton.
Endocrine reviews 2003 Apr;24(2):218-35
-
Mechanisms of glucocorticoid action in bone cells.
Journal of cellular biochemistry 1994 Nov;56(3):295-302
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Experimental Models of Hajdu Cheney Syndrome and Related Disorders | Lecture | Gordon Conference - Bone and Teeth | 2018 | Galveston, TX |
Notch Signaling and Genetic Skeletal Disorders | Lecture | University of Pennsylvania | 2018 | Philadelphia, PA |
Notch Signaling and Genetic Skeletal Disorders | Lecture | Brown University | 2018 | Providence, RI |
Notch Signaling - Basic Science for Clinicans | Poster | 2017 ASBMR Annual Meeting | 2017 | Denver, CO |
Hajdu Cheney Syndrome - 3rd Translational European Society of Endocrinology (ESE) Bone Course | Lecture | 8th Skeletal Endocrinology Meeting | 2017 | Mantova, Italy |
Notch and Hajdu Cheney Syndrome - 2nd Translational European (ESE) Bone Course | Lecture | 7th Skeletal Endocrinology | 2015 | Brescia, Italy |
Señalización Notch | Lecture | XX Congreso de la Sociedad Española de Investigación Ósea y Metabolismo Min | 2015 | Bilbao, Spain |
Osteoporosis por Glucocorticoides | XX Congreso de la Sociedad Española de Investigación Ósea y Metabolismo Min | 2015 | Bilbao, Spain | |
Hajdu Cheney Syndrome | Lecture | Skeletal Endocrinology | 2014 | Brescia, Italy |
Notch and the Skeleton | Lecture | Louis Avioli Lecture | 2014 | St. Louis, MO |
Mechanisms of Glucocorticoid Action in Bone | American Academy of Allergy, Asthma and Immunology | 2014 | San Diego, CA | |
Visiting Professor Universita di Brescia | Universita di Brescia | 2014 | Brescia, Italy | |
Notch Signaling and Skeletal Disorders (6th Skeletal Endorcrinology Meeting and First Translational European Society of Endocrinology Bone Course) | 2014 | Brescia, Italy | ||
From Growth Factors to Glucocorticoids | Talk | NIDDK 60th Anniversary Symposium and Reception at ASBMR | 2010 | Toronto, Canada |
Effects of Glucocorticoids on Bone Cells | Lecture | 2010 Update on Bone Involvement in Arthritis | 2010 | Genova, Italy |
Safety of Bisphosphonates with Particular Reference to Bone Quality, Fracture Healing and Implant Integration | Lecture | New York Academy of Medicine | 2010 | New York, NY |
Glucocorticoid-Induced Osteoporosis: From Bench to Bedside | Lecture | New York Academy of Medicine | 2010 | New York, NY |
New Treatment Modalities in Osteoporosis | Lecture | American Association of Clinical Endocrinologists | 2010 | Boston, MA |
Notch and the Skeleton | Lecture | Maine Medical Center Research Institute | 2010 | Portland, ME |
Mechanisms of Anabolic Agents in Bone | Lecture | The Lowell P. Weicker, Jr. General Clinical Research Center (GCRC) Seminar | 2010 | Farmington, CT |
Notch, a Novel Signal Controlling Osteoblastic Cell Fate | Lecture | 6th International Congress GIO | 2009 | Siena, Italy |
Glucocorticoid Induced Osteoporosis | Lecture | Delaware Rheumatology Society | 2009 | Denver, CO |
Clinical Management Decisions in Osteoporosis | Lecture | Clinical 411 | 2009 | Denver, CO |
Notch Signaling in Bone Development and Homeostasis | Lecture | The Endocrine Society’s 91st Annual Meeting – ENDO 09 | 2009 | Washington, DC |
Regulation of Osteoblastic Cell Differentiation and Function by CTGF | Lecture | 3rd International Meeting on Skeletal Endocrinology | 2009 | Brescia, Italy |
Actions of Glucocorticoids on the Osteoblast and Their Reversal by Anabolic Therapies | Lecture | 5th International Congress on Glucocorticoid Induced Osteoporosis | 2007 | Napoli, Italy |
A Novel BMP/Wnt Antagonist | Lecture | Gordon Research Conferences – Small Integrin-Binding Proteins | 2007 | Biddeford, Maine |
Inhibitors of Osteoblast Differentiation | Lecture | 2nd Conference on Skeletal Biology and Medicine | 2007 | New York, NY |
Post Menopausal Osteoporosis | Lecture | Wyndham Hospital | 2006 | Wyndham, CT |
Mechanisms of Glucorticoid Action in Bone: Relevance to Osteoporosis | Lecture | Hallet Center for Diabetes and Endocrinology – Rhode Island Hospital | 2005 | Providence, RI |
Mechanism of Glucocorticoid Action in Bone | Lecture | University of Colorado Health Sciences Center | 2005 | Aurora, CO |
Mechanisms of Glucocorticoid Action on Osteoblasts | Lecture | 4th International Congress on Glucocorticoid Induced Osteoporosis | 2005 | Trieste, Italy |
Mechanisms of Action of Glucocorticoids in Bone | Lecture | Third International Conference on Osteoporosis in Men | 2005 | Genoa, Italy |
Signals Determining Osteoblastic Cell Fate and Function | Lecture | Third International Conference on Children’s Bone Health | 2005 | Sorrento, Italy |
Glucocorticoid Induced Osteoporosis | Lecture | Endocrine Grand Rounds- Stanford University | 2005 | Palo Alto, CA |
Glucocorticoid Induced Osteoporosis | Lecture | Medical Grand Rounds- Saint Francis Hospital and Medical Center | 2005 | Hartford, CT |
Management of Post-Menopausal Osteoporosis | Lecture | Medical Grand Rounds- University of West Virginia | 2005 | Morgantown, WV |
Mechanisms of Glucocorticoid Action In Bone | Lecture | Endocrinology Grand Rounds- Vanderbilt University | 2005 | Nashville, TN |
Glucocorticoid Induced Osteoporosis | Lecture | Rheumatology Grand Rounds- Yale University | 2005 | New Haven, CT |
Regulation of Osteoblastogenesis | Lecture | Skeletal Endocrinology 2004 | 2005 | Arzaga, Italy |
Mechanisms of Glucocorticoid Induced Osteoporosis | Lecture | 4th Global Arthritis Research Network (GARN) | 2004 | Montreal, Canada |
New Concepts in the Screening and Treatment of Osteoporosis | Lecture | Family Medicine Grand Rounds | 2004 | Bethesda, MD |
Glucocorticoid Induced Osteoporosis | Lecture | Rheumatology Rounds | 2004 | Manhasset, NY |
Mechanisms of Glucocorticoid Action in Bone | Lecture | Lupus 2004 - 7th International Congress SLE and Related Conditions | 2004 | New York, NY |
Osteoporosis | Lecture | Medical Grand Rounds- Bryn Mawr Hospital | 2004 | Bryn Mawr,PA |
Mechanisms of Glucocorticoid Action in Bone Relevance to Glucocorticoid Induced Osteoporosis | Lecture | Rheumatology Grand Rounds | 2004 | Mineola, NY |
Current Approaches to the Management of Osteoporosis | Lecture | Medical Grand Rounds- Bridgeport Hospital | 2004 | Bridgeport, CT |
Mechanisms of Glucocorticoid Action in Bone | Lecture | Rheumatology Grand Rounds | 2003 | Seattle, WA |
Management of Osteoporosis in Light of the Women's Health Initiative | Lecture | Medical Grand Rounds | 2003 | Seattle, WA |
A Scientific Approach to Glucocorticosteroid-Induced Osteoporosis | Lecture | The State of the Art in the Management of Osteoporosis | 2003 | Washington, DC |
Mechanisms of Action of Glucocorticoids in Bone: Relevance to Osteoporosis in Men | Lecture | Second International Conference on Osteoporosis in Men | 2003 | Genoa, Italy |
Mechanisms of Glucocorticoid Action and Relevance to Glucocorticoid Induced Osteoporosis Growth Factors as Determinants of Bone Mass | Lecture | VI Congreso Sociedad Iberoamericana de Osteologia y Metabolismo Mineral | 2003 | Quito, Ecuador |
Post-Menopausal Osteoporosis | Lecture | Harrington Memorial Hospital Medical Grand Rounds | 2003 | Southbridge, MA |
Glucocorticoid Induced Osteoporosis | Lecture | Hamot Medical Center Medical Grand Rounds | 2002 | Erie, PA |
Glucocorticoid Steroid Induced Osteoporosis | Lecture | Pascack Valley Hospital Medical Grand Rounds | 2002 | Westwood, NJ |
Controversies in Women's Health | Lecture | Center for Women's Health & Medicine at Mercy | 2002 | Baltimore, MD |
Osteoporosis | Lecture | Riverside Regional Medical Center Medical Grand Rounds | 2002 | Newport News, VT |
Skeletal Growth Factors | Lecture | 24th Annual Meeting of the American Society for Bone and Mineral Research | 2002 | San Antonio, TX |
Insulin Like Growth Factors and Future Therapies in Osteoporosis | Lecture | 12 corso Nazionale sulle Malattie Metaboliche dell'Osso | 2002 | Turin, Italy |
Glucocorticoid Induced Osteoporosis / Inflammatory Bowel Disease | Lecture | Lenox Hill Hospital Gastroenterology Grand Rounds | 2002 | New York, NY |
Effect of Glucocorticoids on the Skeleton | Lecture | 33rd Annual Symposium | 2002 | Barcelona, Spain |
Glucocorticoid Induced Osteoporosis | Lecture | 16th Annual Meeting of the Metabolic Bone Disease Society of Colorado | 2002 | Denver, CO |
Selected Topics in Osteoporosis | Lecture | Baystate Medical Center Medical Grand Rounds | 2002 | Springfield, MA |
Mechanisms of Glucocorticoid Action in Bone | Lecture | Rheumatology Grand Rounds - Massachusetts General Hospital | 2001 | Boston, MA |
GH and Bone: GH/IGF and Osteoblast Function | Lecture | 5th International HYPOCCS Symposium | 2001 | Antwerp, Belgium |
Role of Bisphosphonates and Estrogens in the Therapy of Osteoporosis | Lecture | Annual Meeting of the Sociedad Peruana del Clinaterio | 1999 | Lima, Peru |
Local Factors in the Regulation of Bone Remodeling | Lecture | 7th Congress, Spanish Society for Bone Research and Mineral Metabolism | 1999 | Sitges, Spain |
Basic Pathophysiology of Glucocorticoid Action on Bone | Lecture | 81st Annual Meeting of the Endocrine Society | 1999 | San Diego, CA |
Expression and Regulation of Hepatocyte Growth Factor/Scatter Factor in Osteoblast Cultures | Lecture | International Bone and Mineral Society | 1999 | Gallipoli, Italy |
Effects of Glucocorticoids on Bone Formation and Coordinator | Lecture | 1st International Congress, Glucocorticoid Induced Osteoporosis | 1999 | Lake Garda, Italy |
Mechanisms of Glucocorticoid Action in Bone Relevance to Osteoporosis | Lecture | Keystone Symposia on Molecular & Cellular Biology | 1999 | Tahoe City, CA |
Bone Matters: Current Clinical Research in the Management of Osteoporosis | Lecture | American Society for Bone and Mineral Research | 1998 | San Francisco, CA |
Skeletal Growth Factors | Lecture | Women’s Health Symposium | 1998 | Santiago, Chile |
Effects of IL-6 on Matrix Metalloproteinases: Implications to Bone Remodeling and the Insulin-Like Growth Factor Axis | Lecture | IV Workshop on Osteobiology | 1997 | Parma, Italy |
Growth Factors and Bone | Lecture | 1997 | Singapore | |
Assessment of the Growth Hormone/IGF-I Axis in Aging | Lecture | Symposium Sponsored by the National Institute for Aging Bethesda, Maryland, | 1997 | Bethesda, MD |
Effect of Glucocorticoids on Insulin-Like Growth Factors and Their Binding Proteins | Lecture | 2nd International Conference on Steroids and Bone | 1997 | Siena, Italy |
Osteoporosis: Etiology, Pathophysiology and Current Medical Management | Lecture | Symposium Sponsored by New York State Academy of Family Physicians | 1997 | Lake Placid, NY |
In Vitro and In Vivo Actions of Growth Factors on the Skeleton | Lecture | VII International Conference on Bone Morphometry | 1996 | Sardinia, Italy |
Growth Factors in Bone Metabolism | Lecture | IV Congreso Chileno de Osteologia y Metabolismo Mineral | 1996 | Santiago, Chile |
Role of Insulin-Like Growth Factor in Bone Metabolism | Lecture | 10th International Congress of Endocrinology | 1996 | San Francisco, CA |
Skeletal Insulin-Like Growth Factors and Their Binding Proteins | Lecture | Symposium Pharmaco-Clinique Roussel Uclaf: Role of Growth Factors in Skelet | 1996 | Paris, France |
Role of Insulin-Like Growth Factor I (IGFI) and IGF Binding Proteins in Bone | Lecture | 20th Birthday of the Belgian Bone Club | 1995 | Brussels, Belgium |
Actions of Deflazacort and Other Glucocorticoids on Osteoblasts | Lecture | Satellite of First International Conference on Steroids and Bone | 1994 | Florence, Italy |
Steroids, Growth Factors and Bone Turnover | Lecture | First International Conference on Steroids and Bone | 1994 | Florence, Italy |
Insulin-Like Growth Factor, An Autocrine Regulator of Skeletal Cells | Lecture | Third International Symposium on Insulin-Like Growth Factors | 1994 | Sydney, Australia |
Biology of Cartilage and Bone | Lecture | European Research Conferences | 1992 | Obernai, France |
Insulin-Like Growth Factor and the Local Regulation of Bone Formation | Lecture | The Sixth International Congress on Bone Morphometry | 1992 | Lexington, KY |
Cytokines and Local Growth Factors in the Regulation of Bone Metabolism | Lecture | Effects of Space Travel on the Musculoskeletal System | 1990 | Bethesda, MD |
Cultures of Fetal Rat Calvariae to Study Bone Formation | Lecture | American Society for Bone and Mineral Research | 1984 | |
Local Skeletal Growth Factors in Osteoporosis | Lecture | Consensus Development Conference in Osteoporosis-NIH | 1984 | Bethesda, MD |
Bone Derived Growth Factor | Lecture | Workshop on Local Mechanisms Regulating Bone Formation, NIH | 1983 | Bethesda, MD |
Local Regulation of Bone Growth | Lecture | Gordon Research Conferences - Bone and Teeth | 1983 | Meriden, NH |